Teva launches generic of Skelaxin

NORTH WALES, Pa. — Teva has introduced its generic of Skelaxin (metaxalone) tablets, the company announced Tuesday. The drug is indicated as an adjunctive therapy to relieve discomfort associated with acute, painful musculoskeletal conditions.

“Our customers count on Teva for a continuous supply of new generic products,” Teva COO North American generics Maureen Cavanaugh said. “With the launch of metaxalone tablets, we add another quality product to our broad line of affordable generic pharmaceuticals.”